The store will not work correctly when cookies are disabled.
6-Morpholino-N,N-bis(pyridin-2-ylmethyl)pyrimidin-4-amine
ID: ALA4571915
PubChem CID: 155563200
Max Phase: Preclinical
Molecular Formula: C20H22N6O
Molecular Weight: 362.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(CN(Cc2ccccn2)c2cc(N3CCOCC3)ncn2)nc1
Standard InChI: InChI=1S/C20H22N6O/c1-3-7-21-17(5-1)14-26(15-18-6-2-4-8-22-18)20-13-19(23-16-24-20)25-9-11-27-12-10-25/h1-8,13,16H,9-12,14-15H2
Standard InChI Key: UIUGVHDYDGPCNZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
14.0724 -21.4987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0713 -22.3224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7835 -22.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4972 -22.3219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4944 -21.4951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7817 -21.0857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3591 -22.7345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2097 -22.7335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2110 -23.5548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9209 -22.3197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4998 -23.9645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6334 -22.7272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7904 -23.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0797 -23.9623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0805 -24.7845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7980 -25.1959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5058 -24.7804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6300 -23.5510 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.3376 -23.9584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0497 -23.5446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0458 -22.7190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3336 -22.3153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6554 -22.3168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9454 -22.7214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9405 -23.5430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6519 -23.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3640 -23.5523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
4 8 1 0
8 9 1 0
8 10 1 0
9 11 1 0
10 12 1 0
11 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 11 1 0
12 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 12 1 0
7 23 1 0
7 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 362.44 | Molecular Weight (Monoisotopic): 362.1855 | AlogP: 2.31 | #Rotatable Bonds: 6 |
Polar Surface Area: 67.27 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.75 | CX LogP: 2.41 | CX LogD: 2.32 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.67 | Np Likeness Score: -1.70 |
References
1. Camacho-Hernandez GA, Stokes C, Duggan BM, Kaczanowska K, Brandao-Araiza S, Doan L, Papke RL, Taylor P.. (2019) Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for α7 nAChRs., 62 (22): [PMID:31675224] [10.1021/acs.jmedchem.9b01467] |